Leiden University Scholarly Publications

Search results

(1 - 9 of 9)

: Patients with obesity should be recognised as a special patient population during drug development of antibacterial and antifungal agents

: Pooled population pharmacokinetic analysis and dose recommendations for ciprofloxacin in intensive care unit patients with obesity

: Ciprofloxacin pharmacokinetics after oral and intravenous administration in (morbidly) obese and non-obese individuals

: Implications for IV posaconazole dosing in the era of obesity

: Correction to: Tobramycin clearance is best described by renal function estimates in obese and nonobese Individuals: results of a prospective rich sampling pharmacokinetic study

: Pharmacokinetics and pharmacodynamics of posaconazole

: Population pharmacokinetics of vancomycin in obesity: finding the optimal dose for (morbidly) obese individuals

: A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients

: Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults